RAD6B Loss Disrupts Expression of Melanoma Phenotype in Part by Inhibiting WNT/β-Catenin Signaling
- 9 November 2020
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 191 (2) , 368-384
Abstract
No abstract availableKeywords
Funding Information
- Barbara Ann Karmanos Cancer Institute
- National Cancer Institute (P30 CA022453)
- Wayne State University
- National Institutes of Health
- Office of the Vice President for Research, Wayne State University
This publication has 64 references indexed in Scilit:
- What is bad in cancer is good in the embryo: Importance of EMT in neural crest developmentSeminars in Cell & Developmental Biology, 2012
- β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient MelanomasCancer Cell, 2011
- In melanoma, beta-catenin is a suppressor of invasionOncogene, 2011
- Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survivalProceedings of the National Academy of Sciences, 2009
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- A genomic screen identifies TYRO3 as a MITF regulator in melanomaProceedings of the National Academy of Sciences, 2009
- Activated Wnt/ß-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma modelProceedings of the National Academy of Sciences, 2009
- The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to Mesenchymal TransitionJournal of Biological Chemistry, 2007
- Proneural genes and the specification of neural cell typesNature Reviews Neuroscience, 2002
- The yeast DNA repair gene RAD6 encodes a ubiquitin-conjugating enzymeNature, 1987